Haufinyane tjena, Nantong Chanyoo e entse ketsahalo e 'ngoe ea bohlokoa nalaneng!Ka boiteko ba nako e fetang selemo, KDMF ea pele ea Chanyoo e amohetsoe ke MFDS.E le moetsi e moholo oa Rosuvastatin Calcium Chaena,re lakatsa ho bula khaolo e ncha 'marakeng oa Korea.Mme lihlahisoa tse ngata li ne li tla hlahisoa lilemong tse 'maloa tse tlang.

Hape, o ka sheba le ho fumana lintlha tsa rona sebakeng sena sa marang-rang:

https://nedrug.mfds.go.kr/pbp/CCBAC03

Rosuvastatin calcium e loketse kalafo ea adjuvant ho bakuli ba nang le hypercholesterolemia ea mantlha (mofuta oa IIa, ho kenyeletsoa heterozygous family hypercholesterolemia) kapa lipemia e tsoakiloeng (mofuta oa IIb) ha ho ja lijo kapa ho ikoetlisa ho sa loka.Rosuvastatin calciumke 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor e khethiloeng.Ka ho thibela HMG-CoA reductase, e fokotsa tlhahiso ea lisele tsa sebete le ho boloka k'holeseterole, ka tsela eo e Theola cholesterol eohle ea mali (TC) le maemo a tlase a "density lipoprotein cholesterol" (LDL-C).

Ho latela data ea Newport, ho tloha ka la 30 Phuptjane 2018 ho isa la 30 Phuptjane 2019, thekiso ea lefats'e ea litokisetso tsa calcium ea rosuvastatin e ne e le US $ 3.461 bilione, phokotso ea selemo le selemo ea 13%;thekiso ea lefats'e ka bophara ea thepa e tala ea rosuvastatin calcium e ne e le lithane tse 151.09, Keketseho ea selemo le selemo ea 14%

Rona,Changzhou Pharmaceutical Factory(moetsi oa motlatsi: Nantong Chanyoo Pharmatech Co., Ltd.) e ile ea inehela ho mofani e moholo ka ho fetisisa oa Rosuvastatin API.